Consensus Beta Bionics, Inc.

Stocks

BBNX

US08659B1026

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-17 EDT			5-day change	1st Jan Change
17.29 ^USD	+2.31%		+1.53%	-43.26%

07-13	Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating	MT
06-29	Beta Bionics, Inc.(NasdaqGM:BBNX) dropped from Russell 2000 Growth Benchmark	CI

Evolution of the Average Target: Beta Bionics, Inc.

Evolution of the Target Price: Beta Bionics, Inc.

Changes in Analyst Recommendations: Beta Bionics, Inc.

28459169a85.6i6VcZxiqgqxqQU4XQ9r0SuU9ukxoSl7qty6NxmKbeU.gxrUIq46klPImGFPaTkCqx3txadSwlFOyerjVHXaAtffedpJ1k_cW4PeVA~9e9a4fa61bc3b069ec88c0bce1a91da6

Analysts' recommendations: Beta Bionics, Inc.

07-13	Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating	MT
05-18	BofA Adjusts Price Target on Beta Bionics to $11 From $23	MT
04-15	Truist Cuts Price Target on Beta Bionics to $18 From $25, Keeps Buy Rating	MT
02-09	UBS Initiates Coverage on Beta Bionics With Buy Rating, $24 Price Target	MT
02-02	Truist Trims Price Target on Beta Bionics to $25 From $37, Keeps Buy Rating	MT
01-27	TD Cowen Initiates Beta Bionics at Hold WIth Price Target $17	MT
01-09	Top Midday Decliners	MT
01-09	Beta Bionics Shares Fall After BofA Securities Downgrade	MT
01-09	BofA Securities Downgrades Beta Bionics to Neutral From Buy, Adjusts Price Target to $28 From $33	MT
12-18	Truist Securities Adjusts Price Target on Beta Bionics to $37 From $32, Maintains Buy Rating	MT
25-10-29	Truist Raises Price Target on Beta Bionics to $32 From $28, Keeps Buy Rating	MT
25-10-01	Goldman Sachs Upgrades Beta Bionics to Buy From Neutral, Adjusts Price Target to $26 From $18	MT
25-09-22	Truist Raises Price Target on Beta Bionics to $28 From $21, Keeps Buy Rating	MT
25-07-30	Truist Raises Price Target on Beta Bionics to $21 From $18, Keeps Buy Rating	MT
25-06-16	Truist Securities Initiates Beta Bionics at Buy With $26 Price Target	MT
25-05-30	Wolfe Research Initiates Coverage on Beta Bionics With Outperform Rating, $20 Price Target	MT
25-05-30	Goldman Sachs Initiates Coverage on Beta Bionics With Neutral Rating, $16 Price Target	MT
25-02-24	Stifel Initiates Beta Bionics at Buy With $25 Price Target	MT
25-02-24	Piper Sandler Initiates Beta Bionics at Overweight With $26 Price Target	MT
25-02-24	Leerink Partners Initiates Beta Bionics at Outperform With $28 Price Target	MT
25-02-20	Baird Initiates Beta Bionics at Neutral With $20 Price Target	MT
25-02-20	Ladenburg Thalmann Initiates Beta Bionics at Buy With $31 Price Target	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	BETA BIONICS, INC.					+14.52%
	THERMO FISHER SCIENTIFIC, INC.					+11.04%
	DANAHER CORPORATION					+18.98%
	INTUITIVE SURGICAL, INC.					+45.95%
	BOSTON SCIENTIFIC CORPORATION					+64.5%
	EDWARDS LIFESCIENCES CORPORATION					+15.48%
	SIEMENS HEALTHINEERS AG					+29.98%
	AGILENT TECHNOLOGIES, INC.					+21.19%
	WATERS CORPORATION					+11.96%
	RESMED, INC.					+25.33%
	Average					+25.89%
	Weighted average by Cap.					+25.91%